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In everyday clinical practice, it is not always clear if and when exactly in the fertility work-up a diagnostic laparoscopy
should be offered. The aim of this review is to analyse the available evidence with respect to alternative diagnostic
methods for detecting tuboperitoneal infertility and with respect to the position of diagnostic laparoscopy in
women with infertility. A literature search of the National Library of Medicine and the National Institutes of
Health (PubMed) was performed using the key words ‘diagnostic laparoscopy and infertility’. The study methodology
was carefully considered in an effort to present conclusions preferably based on randomized controlled trials (RCTs).
The routine use of diagnostic laparoscopy for the evaluation of all cases of female infertility is currently under debate.
According to data published in retrospective non-controlled studies, diagnostic laparoscopy after several failed cycles
of ovulation induction enables the detection of a significant proportion of pelvic pathology amenable to treatment.
A Cochrane review has shown that laparoscopic ovarian diathermy in clomiphene-resistant polycystic ovarian
syndrome is at least as effective as gonadotrophin treatment, and results in a lower multiple pregnancy rate. The
role of laparoscopy before the start of treatment with intrauterine insemination is controversial, according to one
RCT. In women with bilateral ultrasonically visible hydrosalpinges, two RCTs have demonstrated increased implan-
tation and pregnancy rates in IVF cycles after salpingectomy. Although RCTs which have studied the benefit of
laparoscopic surgery in moderate or severe endometriosis are still lacking, its value has generally been accepted.
In conclusion, some specific clinical settings, solid evidence is available to recommend the use of diagnostic laparo-
scopy in current fertility practice. There is however a need for more RCTs to answer remaining questions regarding
its value in the diagnosis and treatment of some patients with infertility.
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Introduction
The position of diagnostic laparoscopy in current fertility practice
is still under debate. Until recently, laparoscopy was the final diag-
nostic procedure of the female fertility exploration, as outlined by
the American Fertility Society in 1992 and by the World Health
Organization guidelines (Rowe et al., 1993). In 1997, Glatstein
et al. (1997) reported that 89% of all reproductive endocrinologists
in the USA routinely performed a laparoscopy in the diagnostic
work-up of infertility. However, some investigators showed that
the diagnostic laparoscopy did not reveal any pathology or only
minimal and mild endometriosis in 40–70% of all cases
(Forman et al., 1993).
Already by the mid-1990’s, the test ‘diagnostic laparoscopy’
failed to be an ideal predictor for infertility (Collins et al.,
1995). These findings convinced some authors to challenge the
need for this procedure in the work-up of infertility (Fatum
et al., 2002). Worldwide, diagnostic laparoscopy is increasingly
bypassed by IVF clinics in an effort to be cost-effective
on the one hand and on the other hand, to protect patients
from possible hazards of surgical complications and general
anaesthesia.
Disadvantages of diagnostic laparoscopy include the need for
general anaesthesia, patient’s anxiety and the possibility of
adhesion formation. In a large Finnish follow-up study, the com-
plication rate of diagnostic laparoscopy was 0.6 per 1000 pro-
cedures (Ha¨rkki-Sire´n et al., 1999). However, advantages
include the possibility to perform both diagnosis and therapy at
the same time, and the opportunity to combine the laparoscopy
with the hysteroscopic exploration of the uterine cavity with an
endometrial biopsy, all as part of day care surgery. In this
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review paper, an effort is made to define the position of diagnostic
laparoscopy in current fertility practice. A literature search of the
National Library of Medicine and the National Institutes of Health
was done, using the MeSH terms ‘diagnostic laparoscopy and
infertility’. The study methodology was carefully considered to
present conclusions preferably based on randomized controlled
trials (RCTs), if at all available.
We will first address the question whether alternative diagnostic
procedures to evaluate tuboperitoneal infertility are reliable
enough to replace the laparoscopy. Subsequently, we will
discuss the position of diagnostic laparoscopy in the context of
treatment for ovulation induction, intrauterine insemination (IUI)
and IVF based on two questions: (i) is it necessary to perform a
diagnostic laparoscopy before starting these respective infertility
treatments to detect significant tuboperitoneal pathology with
therapeutic consequences and with impact on the treatment’s
cumulative ongoing pregnancy rate? and (ii) is it still indicated
to perform a laparoscopy after several failed treatment cycles
with ovulation induction or IUI/IVF to enhance the couple’s
success rate? At the end of this paper we will present some con-
clusions regarding the level of evidenceavailable in the current litera-
ture and the strength of recommendations.
Alternative diagnostic procedures for evaluating tubal
infertility and endometriosis
The prevalence of peritubal adhesions in infertile patients ranges
from 10 to 23% (al Badawi et al., 1999). Thus the first topic to
be addressed is the reliability of alternative diagnostic methods
for examining the presence of tuboperitoneal infertility, based
on medical history, hysterosalpingography (HSG) and serum
Chlamydiascreening.
Medical history and tuboperitoneal infertility
The positive predictive value of history taking, based on symp-
toms suggestive for previous pelvic inflammatory disease (PID),
a history of abnormal vaginal discharge and a previous diagnosis
of a lower genital tract infection was only 56, 59 and 35%, respec-
tively, in predicting tuboperitoneal infertility (Hubacher et al.,
2004). With respect to pelvic endometriosis, the predictive value
of each symptom or even a combination of symptoms in predicting
its presence, remains uncertain. Indeed, these symptoms have a
low specificity and a significant proportion of women affected
by endometriosis, are without any symptoms (Kennedy et al.,
2005).
HSG and HyCoSy
The HSG provides a morphological view of the uterine cavity, the
Fallopian tubes and their patency. According to a meta-analysis,
HSG has a reasonable specificity (83%) but a low sensitivity
(65%) to document patency of the Fallopian tubes (Swart et al.,
1995). Fecundability is reduced in the presence of bilateral occlu-
sion and/or hydrosalpinx (odds ratio, OR 0.30; 95% confidence
interval, CI 0.13–0.71), but not in the presence of one-sided
tubal occlusion or hydrosalpinx (OR 0.81; 95% CI 0.47–1.40)
(Mol et al., 1997b). Furthermore, an HSG performed with oil-
based contrast media may have therapeutic value in women
with infertility. According to a meta-analysis by Watson and
co-workers (1994), a higher conception rate has been demon-
strated in patients where HSG was performed with oil-based con-
trast media than those with water-based contrast media (OR 1.89;
95% CI 1.33–2.68), especially in the subgroup of patients with
idiopathic infertility (OR 2.71; 95% CI 1.94–3.78). According
to a randomized study by Ogata et al. (1993), the conception
rate was three times higher in infertile women having an HSG per-
formed with oil- soluble contrast medium when compared with a
control group without HSG. However, in everyday clinical prac-
tice HSG is generally performed with water-based media to
prevent allergic reactions despite the fact that no clear additional
benefit has been reported with regard to fecundability after HSG
with water-based media. The HSG has no value in the diagnosis
of endometriosis.
The technique of HSG has several possible adverse effects.
Lower abdominal pain and discomfort are commonly experienced
by patients undergoing HSG, and can be remembered for years
afterwards as one of the most painful outpatient exams in gynae-
cology. An HSG can induce or exacerbate PID, leading to perito-
nitis, pelvic abscess and very exceptionally even to death (Chuang
et al., 1971). Uterine perforation and post-examination haemor-
rhage are a possibility. Other complications include granuloma
formation and vascular intravasation. Hypersensitivity reactions
to iodine exist with any of the HSG media, but allergic reactions
are rare. Finally, the ionizing radiation used for HSG can be detri-
mental to an undiagnozed early pregnancy.
A multicentre RCT comparing cumulative pregnancy rates
(CPR) in a group where HSG was followed by diagnostic laparo-
scopy versus a group where diagnostic laparoscopy alone was per-
formed, showed no significant difference in CPR at 18 months
(Perquin et al., 2006).
The authors question the added value of HSG performed at
an early stage in the fertility work- up prior to laparoscopy
and dye.
The prognostic significance of HSG and laparoscopy for fertility
outcome was studied and published in a large prospective cohort
study (Mol et al., 1999).Unilateral and bilateral tubal occlusion
at HSG and laparoscopy were related to treatment independent
pregnancy. The adjusted fecundity rate ratios (FRR) of one-sided
tubal occlusion at HSG was 0.80, whereas two-sided tubal occlu-
sion had a FRR of 0.49. In the case of laparoscopy, the adjusted
FRRs were 0.51 and 0.15, respectively, for one-sided and two-
sided tubal occlusion. A laparoscopy showing two-sided occlusion
after a normal or one-sided occluded HSG was found in 5% of the
patients and the treatment-independent conception rate in this case
was virtually zero. A normal laparoscopic examination after two-
sided occluded HSG was found in 42% of all patients; in these
cases fertility prospects were only slightly impaired with a three-
year cumulative ongoing intrauterine pregnancy rate of 9%. On the
other hand, fertility prospects were strongly impaired in cases
where laparoscopy showed one-sided and two-sided occlusions
after a two-sided occluded HSG; the adjusted FRR were 0.38
and 0.19, respectively. The authors suggest that performing a diag-
nostic laparoscopy after a two-sided occluded HSG is very useful
since it enables a division between two groups with significantly
different fertility prospects. Furthermore, laparoscopy can be
delayed after normal HSG for at least 10 months because of the
very low probability of only 5% that bilateral tubal occlusion
may be found.
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Hysterosalpingo Contrast Sonography (HyCoSy) is an attractive
alternative to HSG because the patient is not exposed to X-rays or
iodinated contrast media. Fallopian tubal patency is assessed using
transvaginal ultrasonography and a galactose microbubble con-
trast medium. The concordance rates on the assessment of tubal
patency between HyCoSy and HSG are similar, making this ultra-
sound diagnostic tool an attractive option for the outpatient screen-
ing for tubal patency. With reference to the pregnancy rates, a case
controlled clinical study has demonstrated that allocation of
patients screened as normal with HyCoSy to treatments that rely
on an accurate assessment of tubal patency does not change the
conception rates (Hamilton et al., 2003).
Serum CAT
The presence of Chlamydia antibodies (by Chlamydia antibody
testing or CAT) is indicative of an earlier infection with Chlamy-
dia trachomatis, the most important etiologic factor of PID. The
accuracy of serum Chlamydial antibodies in the diagnosis of
tubal pathology has been scrutinized in a meta-analysis by Mol
and co-workers (Mol et al., 1997a). The discriminative capacity
of Chlamydia antibody titers by means of ELISA, microimmuno-
fluorescence or immunofluorescence in the diagnosis of any tubal
pathology is comparable with that of HSG in the diagnosis of tubal
occlusion or hydrosalpinx as indicated by comparable receiver
operating characteristics (ROC) curves.
Summary ROC curves of studies using ELISA or (micro)
immunofluorescence demonstrated a better discrimination when
compared with the summary ROC curve of studies using immuno-
peroxidase assay (Mol et al., 1997a). The same authors published
their results with regard to the cost-effectiveness of HSG, laparo-
scopy and CAT in .2000 infertile couples enrolled in the Cana-
dian Infertility Treatment Evaluation Study (Mol et al., 2001).
The diagnostic work-up to detect tubal pathology in infertile
couples should, according to their results, start with CAT in
couples with relatively good-fertility prospects and immediate
HSG in couples with relatively poor-fertility prospects. Relatively
good-fertility prospects were defined by the authors as having a
3-year chance of conception of .14%, whereas relatively poor-
fertility prospects were defined by a 3-year chance of conception
of ,14%.
In summary, both HSG and CAT are reliable diagnostic pro-
cedures as a primary screening tool for infertility due to tubal path-
ology, but not for endometriosis in patients with open Fallopian
tubes. With these data in mind, the discussion about if and when
a diagnostic laparoscopy should still be performed can now be
focused on the following specific clinical infertility situations.
Diagnostic laparoscopy and the treatment of minimal
and mild endometriosis
Whether or not minimal and mild endometriosis should be treated
in case of infertility still remains a seemingly never-ending discus-
sion. The prevalence of endometriosis in the infertile population
(20–68%) is higher than that in the general female population
of reproductive age (2.5–3.3%) (Houston et al., 1987;
Mahmood and Templeton, 1991). Moderate and severe stage
endometriosis leads to disruption of the normal pelvic anatomy,
impairing the reproductive function of the internal genital
organs. Minimal and mild stage endometriosis may impair fertility
by a variety of mechanisms, including toxic factors within the per-
itoneal fluid, impaired folliculogenesis and luteal function. The
monthly fecundity rate is around 7% in stages I–II endometriosis
and the cumulative live birth rate with expectant management in
endometriosis is low (Collins et al., 1995). Although the associ-
ation between minimal and mild endometriosis and infertility
may be incidental, many sound arguments have been presented
to support that the relationship between endometriosis and inferti-
lity is causal as previously reviewed (De Hondt et al., 2006).
According to a meta-analysis by Jacobson and co-workers
(2004b), the ablation of endometriotic lesions with adhesiolysis
to improve fertility in minimal and mild endometriosis is effective
compared to diagnostic laparoscopy alone (Table 1). This recom-
mendation is based upon a systematic review of two similar but
contradictory RCTs performed in Italy (Parazzini et al., 1999)
and in Canada (Marcoux et al., 1997) comparing laparoscopic
ablation or excision and adhesiolysis of endometriotic lesions
versus diagnostic laparoscopy alone. The fact that these two
RCTs have been assembled into one meta-analysis has been criti-
cized (De Hondt et al., 2006) because the Italian study included a
low number of patients (n ¼ 101), had an unequal number of sub-
jects in both randomized groups, did not include a power analysis
or an outcome analysis on the level of monthly fecundity rate or
CPR, and was biased by the fact that a large number of patients
also took GnRH agonists after surgery (Parazzini et al., 1999;
De Hondt et al., 2006).
In the Canadian study in a group of 341 infertile women aged
20–39 years with minimal or mild endometriosis, a higher cumu-
lative probability of ongoing pregnancy after 36 weeks was
observed in the surgically treated group (31%) when compared
with the control group which had received only diagnostic laparo-
scopy (18%) (RR ¼ 1.7; 95% CI 1.2–2.6) (Marcoux et al., 1997).
However, laparoscopic surgical treatment of endometriosis did not
Table 1: Laparoscopic treatment of minimal/mild endometriosis
Laparoscopic
surgery
Diagnostic laparoscopy RR
(n ¼ 172) (n ¼ 169)
Pregnancies
carried
beyond 20
weeks
50 29
36 weeks
cumulative
probability
(Marcoux
et al. 1997)
30.7 17.7 1.7 (1.2–2.6)
(n ¼ 54) (n ¼ 47)
Pregnancy
(Parazzini,
1999)
12 13 NS
(n ¼ 437) Peto OR (95% CI)
Ongoing
pregnancy
at 20 weeks
or live birth
(Jacobson
et al. 2002)
1.64 (1.05–2.57)
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normalize fecundability. Indeed, the monthly fecundity rate
among women who underwent laparoscopic surgery (6.1%),
albeit double as high as in the diagnostic laparoscopy group,
was still much lower than the fecundity rate expected in fertile
women (20%). A second criticism concerns the fact that possibly
the fertility enhancing effect of the laparoscopic treatment of
minimal and mild endometriosis is solely due to the adhesiolysis.
However, the authors of the Canadian RCT clearly mention that in
the 284 women who did not have adhesions, the destruction of the
implants also significantly increased the 36-week cumulative
probability of ongoing pregnancy with a cumulative incidence
ratio of 1.6 (95% CI 1.1–2.5) (Marcoux et al., 1997). The
ESHRE Special Interest Group for Endometriosis who has
recently developed guidelines for the diagnosis and treatment of
endometriosis recommends surgical treatment for minimal or
mild endometriosis in infertile women, but also mentions that
some members of the working group questioned the strength of
the evidence of the recommendations in the meta-analysis of
Jacobson (Kennedy et al., 2005). The number needed to treat
from the trials is 12, but one has to adjust for the prevalence of
endometriosis in the relevant clinical practice. If endometriosis
is diagnosed in 30% of all cases, then the number needed to
treat in that particular setting would ultimately be 12/0.3 ¼ 40,
which is less compelling (Practice Committee ASRM, 2006).
Clearly, there still is a need for further randomized controlled
studies in order to resolve this issue. At the same time, it may
be hard to convince ethical committees about the need for such
studies, and even harder to recruit patients, in view of the
current level of evidence.
Diagnostic laparoscopy and ovulation induction
treatment
Should a diagnostic laparoscopy systematically be performed
before the onset of any ovulation induction treatment? Can a diag-
nostic laparoscopy, performed after several failed ovulation induc-
tion treatment cycles, reveal significant pathology amenable to
surgical treatment with a positive effect on the overall ongoing
pregnancy rate?
These seemingly easy questions are difficult to answer be-
cause the very few studies available are all retrospective and
non-controlled.
Laparoscopy before ovulation induction treatment
The available evidence on the role of laparoscopy before ovulation
induction merely focuses on the comparison between HSG and
laparoscopy findings for the diagnosis of tubal pathology, the diag-
nosis and treatment of adhesions and the treatment of minimal and
mild endometriosis.
With regard to the routine use of HSG prior to laparoscopy in
the fertility work-up, we refer to the multicentre RCT by
Perquin et al. (2006). With regard to the CPRs at 18 months, no
significant differences were found in 344 women randomized to
an intervention group with HSG followed by diagnostic laparo-
scopy (CPR at 18 months 49% CI 42–57) or a control group
with diagnostic laparoscopy alone (CPR at 18 months 50% CI
43–58%). Regarding the prospective value of HSG and laparo-
scopy we refer to the discussion above (Mol et al., 1999).
The relevance of treating minimal and mild endometriosis will,
as also has been shown above, depend on the prevalence of this
disease in the treated population.
Laparoscopy during ovulation induction treatment
In a retrospective study, Ochoa Capelo et al. (2003) performed a
diagnostic laparoscopy in 92 patients after four failed cycles of
ovulation induction treatment with clomiphene citrate. The
patients had at least four ovulatory cycles, confirmed by basal
body temperature and midluteal phase serum progesterone,
normal HSG findings and male partners with a normal semen
analysis. The presence of pelvic pathology in this study (Ochoa
Capelo et al., 2003) is summarized in Table 2. Laparoscopic find-
ings were strictly normal in only 36% of cases, whereas endo-
metriosis and/or pelvic adhesions were observed in 50 and 33%,
respectively. The authors concluded that laparoscopy continues
to be a useful tool in the work-up of an infertile couple but regret-
tably did not present any pregnancy rates following laparoscopic
surgery (Ochoa Capelo et al., 2003).
With regard to the efficacy of laparoscopic treatment for endo-
metriosis, we refer to the evidence presented above. With regard to
laparoscopic adhesiolysis, there is only one non-randomized con-
trolled study by Tulandi and co-workers (1990) that documented
higher CPRs of 32 and 45% in 12 and 24 months, respectively,
after operative laparoscopy when compared with the 11 and
16% CPRs observed in the non-treated control group. To our
knowledge, these data have not been confirmed in a randomized
controlled study.
Laparoscopic ovarian diathermia in PCOS patients
About 20% of all patients diagnosed with polycystic ovarian
disease (PCOS) and infertility, will not ovulate after ovulation
induction treatment with clomiphene citrate. Even today, the
effective treatment of clomipheneresistant PCOS remains a
challenge for the medical profession. More than 20 years ago,
Gjonnaess (1994) described that laparoscopic electrocoagulation
of the ovarian capsule in 62 clomiphene resistant PCOS patients
resulted in an ovulation rate of 92% and a pregnancy rate of 69%.
In a recent Cochrane review (Farquhar et al., 2005), the efficacy
of laparoscopic drilling of the ovarian capsule (laparoscopic
ovarian diathermy, LOD) by diathermy or laser in clomiphenere-
sistant PCOS has been compared to gonadotrophin treatment
based on a total of 15 RCTs. Only six trials were included for
Table 2: Presence of pelvic pathology on laparoscopy after 4
failed cycles ovulation induction treatment
Findings at laparoscopy n
Normal 33/92
Minimal endometriosis 21/92
Mild endometriosis 6/92
Moderate endometriosis 8/92
Severe endometriosis 2/92
Endometriotic cyst 8/92
Adhesions 30/92
Tubal pathology 1/92
Some patients had concurrent anomalies on diagnostic
laparoscopy. Adapted from Ochoa Capelo et al. (2003).
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further analysis. The primary outcome parameters were the live
birth rate, ovulation rate and ongoing pregnancy rate. Secondary
outcome parameters included the rate of miscarriage, multiple
pregnancy rate, ovarian hyperstimulation syndrome and the total
cost of the respective treatments. The results are shown in
Table 3: there was no evidence of a difference in the live birth
rate or ongoing pregnancy rate between LOD and the
gonadotrophins.
However, the multiple pregnancy rates were lower with ovarian
drilling than with gonadotrophins. There was no evidence of
difference in miscarriage rates between both treatment modalities
(OR 0.8; 95% CI 0.36–1.86). Approximately 50% of all treated
patients will have a live birth and 16% will have a miscarriage
with either treatment. The reviewer’s conclusion is that there is
no difference in the live birth rate and the miscarriage rate in
women with clomipheneresistant PCOS undergoing LOD when
compared with gonadotrophin treatment (Farquhar et al., 2005).
However, the reduction in multiple pregnancy rate in women
undergoing LOD makes this option attractive.
Disadvantages of the LOD procedure include the risks related to
laparoscopic surgery, the need for general anaesthesia, the pos-
sible risk of thermal damage to adjacent organs and ovarian
adhesion formation, and as clearly mentioned in the Cochrane
review, the lack of knowledge concerning the possible negative
long-term effects of this procedure on the ovarian reproductive
function (Farquhar et al., 2005). Moreover it has been pointed
out that the effects observed are usually temporary and the signs
and symptoms of PCOS may return within months following the
LOD (Insler and Lunenfeld, 1993).
Advantages of LOD included the opportunity to treat concomi-
tant pelvic pathology such as peritubal adhesions and endo-
metriosis that can be associated with female infertility.
Furthermore, during the same endoscopic procedure, tubal
patency can be tested, and a hysteroscopy can be performed as
part of the infertility work-up.
In summary, the position of diagnostic laparoscopy in the setting
of ovulation induction is at present not clear due to the lack of sound
scientific evidence provided by good-quality studies. The routine
use of diagnostic laparoscopy to evaluate all cases of female anovu-
latory infertility cannot be advocated, but laparoscopy can offer the
opportunity to assess tuboperitoneal status, to treat pelvic patho-
logy that may limit conception (endometriosis, adhesions), and to
perform LOD. Laparoscopic ovarian diathermia is a good option
when compared with gonadotrophin treatment in the clomiphene
citrate resistant PCOS patient, but counselling should be offered
with regard to the unknown long-term effects of this procedure
on the ovarian function.
Diagnostic laparoscopy and IUI
IUI is an effective fertility enhancing treatment in cases of cervical
factor, unexplained infertility and mild male infertility. Two rele-
vant clinical questions arise in the setting of IUI treatment. First,
does a laparoscopy significantly change the intended treatment
plan in cases where IUI is clinically indicated? Second, should
the laparoscopy be performed before starting IUI or only after
several failed IUI cycles?
Laparoscopy before IUI
Whether laparoscopy should be performed after or before IUI
was studied in a retrospective study, design by Tanahatoe and
co-workers (2003). In a cohort of 495 patients with normal
HSG, laparoscopy was performed before proceeding to IUI treat-
ment due to unexplained, cervical or mild male infertility. The
diagnostic laparoscopy changed the intended treatment in 124 of
495 patients (25%). Excluding the presence of minimal and mild
endometriosis as pelvic pathology without therapeutic impli-
cations, the additional value of diagnostic laparoscopy is limited
to only 40 of 495 patients (8%). The authors conclude that
further prospective studies are needed to determine the real
additional value of diagnostic laparoscopy in IUI.
Recently, the same authors published the results of a random-
ized trial on the role of diagnostic laparoscopy in IUI (Tanahatoe
et al., 2005). A group of 154 patients, suitable for IUI treatment
due to unexplained, cervical or mild male infertility with normal
HSG was randomly allocated to two different treatment strategies.
In the first group (diagnostic laparoscopy first, DLSF), 77 patients
were randomized to receive a diagnostic laparoscopy before IUI
treatment. Further treatment was discontinued in 13 patients,
either because of drop out by not giving informed consent (n ¼
10) or because of pregnancy (n ¼ 3). A diagnostic laparoscopy
was thus performed in the remaining 64 patients. After the laparo-
scopy, IUI treatment was started. Before and during IUI in the
DLSF group, 11 patients dropped out. Of the 31 patients who
became pregnant in this group, 9 conceived before or between
IUI and 22 conceived due to the IUI treatment. In the second
group (IUI first, IUIF), 77 patients were randomized to treatment
with IUI during six treatment cycles. The first three IUI cycles
were performed without controlled ovarian hyperstimulation
(COH). If pregnancy did not occur after three cycles of IUI in
Table 3: Ovarian drilling+medical ovulation induction versus
gonadotrophins only
Study LOD
n/N
Gonadotrophins
n/N
OR 95% CI
Outcome: ongoing pregnancy rate (per couple)
Farquhar et al.
(2002)
5/29 5/21 0.67 (0.17, 2.68)
Bayram
(2004)
56/83 57/85 1.02 (0.53, 1.94)
Lazoviz
(1998)
17/29 9/28 2.99 (1.01, 8.84)
Vegetti
(1998)
2/16 5/13 0.23 (0.04, 1.46)
Total 80/157 76/147 1.08 (0.67, 1.75)
Outcome: multiple pregnancy rate (per ongoing pregnancy)
Farquhar et al.
(2002)
0/5 0/5 Not estimable
Bayram
(2004)
1/56 9/57 0.10 (0.01, 0.79)
Lazoviz
(1998)
0/14 2/9 0.10 (0.00, 2.44)
Vegetti
(1998)
0/3 1/5 0.43 (0.01, 14.08)
Total 1/78 12/76 0.13 (0.03, 0.59)
Adapted from Farquhar et al. (2005).
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the natural cycle, then the patient could choose between continu-
ing IUI in the natural cycle or starting IUI with COH with recom-
binant FSH with a maximum of another three cycles. Further
treatment in the IUIF group was discontinued in 54 patients
because of pregnancy (n ¼ 38) or due to drop out (n ¼ 16). The
remaining 23 patients who did not conceive in the IUIF group
all underwent a diagnostic laparoscopy. The main outcome par-
ameters studied were the pregnancy rate per patient and the pre-
sence of pelvic pathology with therapeutic implications. The
results are presented in Table 4. The pregnancy rate per patient
was 40–50% and the presence of pelvic pathology with therapeutic
implications was high (48–56%) but both outcome variables were
similar in both groups studied (Table 4). Indeed, the at random allo-
cation of patients to one of both study groups did not change signifi-
cantly the ongoing pregnancy rate per patient nor the presence of
pelvic pathology which needed further treatment. The respective
ORs were 1.2 (95% CI 0.7–2.3) for the ongoing pregnancy rate
per patient and 1.4 (95% CI 0.5–3.6) for the presence of pelvic
pathology with therapeutic implications. In the conclusion, the
authors stress the need for further randomized studies to verify
these conclusions since it was impossible to determine a possible
beneficial effect of laparoscopic surgery on the cycle pregnancy
rate or on the CPR since only the crude patient pregnancy rate
was presented in their study. They calculated that at least 1000
patients should have been included to show a difference of 10%
in the cumulative ongoing pregnancy rate (Tanahatoe et al.,
2005). They also mention the considerably high natural pregnancy
rate in both groups (DLSF n ¼ 12; IUIF n ¼ 16) in this study.
Scientific evidence suggests that minimal and mild endometrio-
sis, treated surgically before starting COH (COH and IUI may
increase the cycle pregnancy rate and reduce the time to preg-
nancy) (Werbrouck et al., 2006). Indeed, in a retrospective
cohort study, D’Hooghe and co-workers (Werbrouck et al.,
2006) recently showed data suggesting that it is useful to treat
minimal and mild endometriosis before starting COH and IUI.
This study included 107 women treated during 259 cycles with
COH and IUI, including patients with endometriosis (n ¼ 58;
137 cycles) and unexplained infertility (n ¼ 49; 122 cycles). All
patients with endometriosis had minimal (n ¼ 41; 100 cycles) or
mild (n ¼ 17; 37 cycles) disease that had been laparoscopically
removed within 7 months before the onset of treatment with
COH and IUI. COH was done by using clomiphene citrate (23
cycles) or gonadotrophins (236 cycles) in combination with IUI.
The main outcome measures were the clinical pregnancy rate
per cycle and the cumulative live birth rate after four cycles of
IUI treatment. COH and IUI shortly after the complete laparo-
scopic treatment of minimal and mild endometriosis proved to
be as effective as COH and IUI in patients with unexplained infer-
tility with respective clinical pregnancy rates per cycle of 21 and
19% in minimal and mild endometriosis and 20% in unexplained
infertility. The cumulative live birth rate after four cycles was also
similar in patients with minimal endometriosis (70%), mild endo-
metriosis (68%) and unexplained infertility (66%). The authors
conclude that surgical treatment prior to IUI restores the clinical
pregnancy rate after COH and IUI in women with minimal–
mild endometriosis to the same level as that in women with unex-
plained infertility. This is in contrast with previous studies where
the cycle pregnancy rate and CPR seemed to be lower in patients
with surgically untreated minimal to mild endometriosis than
those with unexplained infertility (Werbrouck et al., 2006). Ran-
domized trials are needed to verify this conclusion, which might
have important implications
Laparoscopy after failed IUI cycles
To the best of our knowledge, no studies are available on the addi-
tive value of laparoscopy after several failed cycles of COH and
IUI. Referring to the above RCT by Tanahatoe and co-workers
(2005), one may be expected to find significant pelvic pathology
(endometriosis all stages, peritubal adhesions) in at least 50% of
cases. Laparoscopic treatment enhances the chance of spontaneous
conception. One may, by extrapolation, expect a higher pregnancy
rate after laparoscopic treatment after several failed IUI cycles. In
conclusion, the position of operative laparoscopy for endometrio-
sis and peritubal adhesions prior to IUI treatment or after several
failed IUI cycles seems a matter of debate. Further, randomized
controlled studies are needed to define the position of laparoscopy
in IUI.
Diagnostic laparoscopy and IVF
Without doubt, the progress in assisted reproductive technology
(ART) has limited the field of reproductive surgery and some
authors radically advocate immediate treatment with ART after
a limited and non-invasive infertility work-up in all infertility
patients (Speroff et al., 1999). Two questions of clinical interest
can be asked. First, is it always mandatory to complete the diag-
nostic infertility phase with a laparoscopy to diagnose and treat
specific pelvic pathology?
Second, is it still indicated to do a laparoscopy after several
failed ART treatment cycles?
Laparoscopy before IVF treatment
Although laparoscopy is still considered to be the gold standard in
the diagnosis of tuboperitoneal infertility, alternative diagnostic
methods, for example, HSG and CAT screening have proven
their clinical value and cost-effectiveness for the diagnosis of
tubal infertility in everyday clinical practice (Mol et al., 2001).
The value of diagnostic laparoscopy in case of abnormal HSG
Table 4: Pregnancy rate per patient and presence of pelvic pathology in
patients treated with either diagnostic laparoscopy first (DLSF) or IUI first
(IUIF)
DLSF
n
IUIF
n
OR (CI)
No
abnormalities
33/64 10/23
Treated
pathology
1.4 (0.5–3.6)
Adhesiolysis 3/64 0/23
Treatment of
endometriosis
28/64 12/23
Fimbriolysis 0/64 1/23
Pregnancy rate/
patient
34/77 38/77 1.2 (0.7–2.3)
Adapted from Tanahatoe et al. (2005).
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findings has been highlighted above (Mol et al., 1999; Perquin
et al., 2006). Using these diagnostic procedures and recommen-
dations, it could be argued that diagnostic laparoscopy can be
avoided in all cases where the available evidence indicates that
IVF is the most appropriate and successful treatment.
However, there is a fair degree of consensus that selected
adnexal pathology, such as hydrosalpinx and ovarian endometrio-
tic cysts, still have to be treated by laparoscopic surgery prior
to IVF.
With respect to hydrosalpinx, two RCTs have demonstrated
increased implantation and pregnancy rates in IVF cycles after
salpingectomy for ultrasonically visible hydrosalpinges
(Dechaud et al., 1998; Strandell et al., 1999). Both these trials
have been included in a recent Cochrane review (Johnson
et al., 2004). The Scandinavian trial (Strandell et al., 1999)
reports a delivery rate per started cycle of 27% in IVF patients
undergoing salpingectomy prior to IVF treatment versus 17%
in the control group without salpingectomy in the
intention-to-treat analysis (P ¼ 0.13; RR ¼ 1.57; 95% CI 0.9–
1.57, not significant). A further subgroup analysis showed a
marked improvement of the delivery rate in patients with hydro-
salpinx visible by ultrasound (40 versus 17%, P ¼ 0.038; RR ¼
2.40; 95% CI 1.09–5.28, on treatment analysis). The highest
improvement in delivery rate occurred in the patients with bilat-
eral ultrasound demonstrable hydrosalpinx (55 versus 16%, P ¼
0.019; RR ¼ 3.48; 95% CI 1.15–10.59, on treatment analysis).
According to the meta-analysis (Johnson et al., 2004), eight
women would have to undergo salpingectomy prior to IVF to
gain one additional live birth. The adverse effect of hydrosalpinx
on ART success rates can be explained by several mechanisms:
the direct toxic effect of tubal fluid on the embryos, the negative
effect of tubal fluid on the endometrium by flushing out embryos,
dilution of implantation factors and prevention of normal
embryonic-endometrial apposition (Erel and Senturk, 2005).
Some authors have warned against the indiscriminate and blind
victimization of the Fallopian tube and have advocated selective
salpingostomy in selected cases (Puttemans et al., 1996). A RCT
of reconstructive tubal surgery versus salpingectomy and IVF in
women with hydrosalpinx is needed to define the position of both
treatment strategies in everyday clinical practice, but can only be
done in countries with a high prevalence of PID (Sabatini and
Davis, 2005).
With respect to endometriosis, unfortunately there are no RCTs
or meta-analyses available to answer the question of whether sur-
gical treatment of moderate and severe endometriosis enhances the
pregnancy rates after spontaneous conception or after IVF
(Kennedy et al., 2005). It is however generally accepted that in
case of infertility, moderate and severe stage endometriosis
should be treated by surgery. There seems to be a negative corre-
lation between the stage of endometriosis and the spontaneous
cumulative pregnancy rate after surgical removal of endometriosis
based upon the evidence of three studies (Adamson et al., 1993;
Guzick et al., 1997; Osuga et al., 2002), but statistical significance
for this statement was only reached in one study (Osuga et al.,
2002). With respect to endometriosis and ART, the recent
ESHRE guidelines state that IVF is appropriate treatment
especially if tubal function is compromised, if there is also male
factor infertility and if other treatments have failed (Kennedy
et al., 2005).
The IVF pregnancy rates are lower in patients with endometrio-
sis than in those with tubal infertility according to a systematic
review of 22 non-randomized studies by Barnhart and co-workers
(2002). These authors conclude that there is an overall 54%
reduction in pregnancy rate after IVF in patients with endometrio-
sis and that the success is poorer with advancing severity of the
disease according to the r-AFS classification system. In some
large databases e.g. SART and HFEA, however, endometriosis
does not seem to adversely affect the reported pregnancy rates
(Templeton et al., 1996). There are no available randomized
trials that have tested the hypothesis that surgical treatment of
endometriosis prior to IVF results in higher pregnancy rates
when compared to expectant management of endometriosis.
Ovarian endometriotic cysts need extra attention in the context of
ART since they can be disadvantageous for IVF treatment: theymay
interfere with COH, create difficulties in aspirating the ovarian fol-
licles during oocyte retrieval, and be held responsible for producing
detrimental substances that are toxic to maturing oocytes, thus
impeding embryo cleavage and implantation. Laparoscopic
surgery for advanced stage endometriosis can be technically very
demanding, time-consuming and high risk with significant post-
operative morbidity and long revalidation. The removal of ovarian
endometriomas prior to COH may be associated with significant
bleeding and destruction of normal adjacent ovarian tissue, thus
diminishing the reproductive ovarian function. There are no ran-
domized studies comparing the live birth rates after IVF treatment
in women who were surgically treated for endometriotic cysts
prior to IVF versus women who were not. In a retrospective case-
controlled study, Garcia-Velasco et al. (2004) demonstrated that
the removal of endometriotic cysts prior to IVF did not improve fer-
tility outcome. Especially in the case of asymptomatic small endo-
metriotic cysts (,3 cm), immediate proceeding to IVF may
reduce the time to pregnancy, treatment costs and the possible detri-
mental effects of inappropriate surgery on the ovarian function.
However, laparoscopic cystectomy of larger symptomatic endo-
metriotic cysts (.4 cm) improves fertility and reduces recurrence
of these cysts when compared to cyst drainage and coagulation
(Beretta et al., 1998; Chapron et al., 2002; Vercellini et al., 2003b).
Laparoscopic treatment of endometriosis after failed IVF
treatment
Finally, is it worth doing laparoscopic surgery in patients with
endometriosis after several failed IVF cycles? Although no ran-
domized trials are available, a retrospective cohort study by
Littman et al. (2005) deserves a closer look. In a series of
29 patients with several failed IVF cycles and endometriosis, a
radical treatment of all endometriotic lesions was performed by
one very experienced laparoscopic surgeon. After surgery, 22
pregnancies were obtained, including 15 spontaneous pregnancies
and 7 pregnancies after repeated IVF treatment. The non-
controlled retrospective evidence in this study stresses the import-
ance of referring patients with severe endometriosis to a centre
with the necessary expertise (Kennedy et al., 2005), in which
case even after several failed IVF cycles, radical and appropriate
surgery may still be beneficial to their reproductive outcome. It
is clear that further randomized controlled studies are needed to
support this view on laparoscopic treatment of severe endometrio-
sis after failed IVF cycles.
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Conclusion
The routine use of diagnostic laparoscopy for the evaluation of all
cases of female infertility is currently under debate.
Current evidence indicates that the surgical treatment of
minimal or mild endometriosis increases the spontaneous preg-
nancy rate in infertile women. The position of operative laparo-
scopy for endometriosis and adhesions prior to IUI treatment or
after failed IUI treatment is a matter of debate, and further pro-
spective randomized studies are needed to test the hypothesis
that this surgical approach can improve the pregnancy rates
during IUI treatment. Randomized trials confirming the role of
the surgical treatment of moderate and severe endometriosis in
infertility are lacking, but its value has generally been accepted.
The position and timing of diagnostic laparoscopy in ovulation
induction treatment is difficult to establish due to a lack of ran-
domized controlled studies. Diagnostic laparoscopy is indicated
in all cases of bilateral anomalies on HSG. Exclusion of bilateral
anatomical tubal pathology by diagnostic laparoscopy could avoid
IVF treatment in these cases. LOD in the treatment of the clompi-
hene resistant PCOS patient is at least as effective as gonado-
trophin treatment, and has a significantly lower risk of multiple
pregnancy. There is however a lack of knowledge regarding the
long-term outcome of this procedure on the reproductive function
of the ovary. It is unknown if surgical treatment of minimal to mild
endometriosis coexisting with PCOS can improve the success of
ovulation induction.
In IVF treatment, laparoscopic salpingectomy of ultrasound
visible hydrosalpinx is indicated because of the beneficial effect
on IVF pregnancy rates. Small asymptomatic endometriotic
cysts probably need no treatment prior to IVF according to non-
randomized evidence.
Generally, there is a need for further RCTs defining the position
and timing of diagnostic/operative laparoscopy in current fertility
practice.
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